Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
1.
Biomedicines ; 11(8)2023 Aug 11.
Article in English | MEDLINE | ID: mdl-37626748

ABSTRACT

Neutrophils are an essential cellular component of innate immunity and control bacterial infections through a combination of intracellular and extracellular killing methods. Although the importance of neutrophils has been established, the exact methods used to handle particular bacterial challenges and the efficiency of bacterial killing remain not well understood. In this study, we addressed how neutrophils eliminate Streptococcus pneumoniae (Spn), a leading cause of community acquired and post-influenza bacterial pneumonia. We analyzed killing methods with variable bacterial:neutrophil concentrations and following priming with PAM3CSK4 (P3CSK), an agonist for Toll-like-receptor 2 (TLR2). Our results show that murine neutrophils display surprisingly weak bactericidal activity against Spn, employing a predominantly extracellular mode of killing at lower concentrations of bacteria, whereas challenges with higher bacterial numbers induce both extracellular and intracellular elimination modes but require TLR2 activation. TLR2 activation increased reactive oxygen species (ROS) and neutrophil extracellular trap (NET) formation in response to Spn. Despite this, supernatants from P3CSK-stimulated neutrophils failed to independently alter bacterial replication. Our study reveals that unstimulated neutrophils are capable of eliminating bacteria only at lower concentrations via extracellular killing methods, whereas TLR2 activation primes neutrophil-mediated killing using both intracellular and extracellular methods under higher bacterial burdens.

2.
Front Immunol ; 13: 1089064, 2022.
Article in English | MEDLINE | ID: mdl-36685578

ABSTRACT

Background: Lung inflammation, neutrophil infiltration, and pulmonary vascular leakage are pathological hallmarks of acute respiratory distress syndrome (ARDS) which can lethally complicate respiratory viral infections. Despite similar comorbidities, however, infections in some patients may be asymptomatic while others develop ARDS as seen with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections for example. Methods: In this study, we infected resistant C57BL/6 and susceptible A/J strains of mice with pulmonary administration of murine hepatitis virus strain 1 (MHV-1) to determine mechanisms underlying susceptibility to pulmonary vascular leakage in a respiratory coronavirus infection model. Results: A/J animals displayed increased lung injury parameters, pulmonary neutrophil influx, and deficient recruitment of other leukocytes early in the infection. Moreover, under basal conditions, A/J neutrophils overexpressed primary granule protein genes for myeloperoxidase and multiple serine proteases. During infection, myeloperoxidase and elastase protein were released in the bronchoalveolar spaces at higher concentrations compared to C57BL/6 mice. In contrast, genes from other granule types were not differentially expressed between these 2 strains. We found that depletion of neutrophils led to mitigation of lung injury in infected A/J mice while having no effect in the C57BL/6 mice, demonstrating that an altered neutrophil phenotype and recruitment profile is a major driver of lung immunopathology in susceptible mice. Conclusions: These results suggest that host susceptibility to pulmonary coronaviral infections may be governed in part by underlying differences in neutrophil phenotypes, which can vary between mice strains, through mechanisms involving primary granule proteins as mediators of neutrophil-driven lung injury.


Subject(s)
COVID-19 , Lung Injury , Murine hepatitis virus , Pneumonia , Respiratory Distress Syndrome , Mice , Animals , Neutrophils , Peroxidase , Mice, Inbred C57BL , SARS-CoV-2 , Proteins
3.
Biochem Biophys Res Commun ; 482(1): 81-86, 2017 Jan 01.
Article in English | MEDLINE | ID: mdl-27810364

ABSTRACT

The P2X7 receptor (P2X7R) is an ATP-gated ion channel that is a key player in oxidative stress under pathological conditions. The P2X7R is expressed in the retinal pigmented epithelium (RPE) and neural retina. Chronic oxidative stress contributes to the pathogenesis of age-related macular degeneration (AMD). Mice lacking Cu, Zn superoxide dismutase (Sod1) developed chronic oxidative stress as well as AMD-like features, but whether the P2X7R plays a causative role in oxidative stress-induced AMD is unknown. Thus, the main purpose of this study was to test if concurrent knockout (KO) of P2X7R could block AMD-like defects seen in Sod1 KO mice. Using multiple approaches, we demonstrate that Sod1 KO causes AMD-like defects, including positive staining for oxidative stress markers, 3-nitrotyrosine and carboxymethyl lysine, thinning of the RPE and retina, thickening of Bruch's membrane, presence of basal laminar and linear deposits, RPE barrier disruption and accumulation of microglia/macrophages. Moreover, we find that Sod1 KO mice accumulate more microparticles (MPs) within RPE/choroid tissues. Concurrent KO of the P2X7R protects against AMD-like defects and MP accumulation in Sod1 KO mice. Together, we show for the first time, that deficiency of P2X7R prevents in vivo oxidative stress-induced accumulation of MPs and AMD-like defects. This work could potentially lead to novel therapies for AMD and other oxidative stress-driven diseases.


Subject(s)
Cell-Derived Microparticles/metabolism , Macular Degeneration/pathology , Macular Degeneration/physiopathology , Oxygen/metabolism , Receptors, Purinergic P2X7/metabolism , Superoxide Dismutase-1/metabolism , Animals , Female , Male , Mice , Mice, Knockout , Oxidative Stress , Stress, Physiological , Superoxide Dismutase-1/genetics
4.
Invest Ophthalmol Vis Sci ; 57(2): 360-71, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26842754

ABSTRACT

PURPOSE: Oxidative stress is a major factor involved in retinal pigment epithelium (RPE) apoptosis that underlies AMD. Drusen, extracellular lipid- and protein-containing deposits, are strongly associated with the development of AMD. Cell-derived microparticles (MPs) are small membrane-bound vesicles shed from cells. The purpose of this study was to determine if oxidative stress drives MP release from RPE cells, to assess whether these MPs carry membrane complement regulatory proteins (mCRPs: CD46, CD55, and CD59), and to evaluate the effects of a thiol antioxidant on oxidative stress-induced MP release. METHODS: Retinal pigment epithelium cells isolated from human donor eyes were cultured and treated with hydrogen peroxide (H2O2) to induce oxidative stress. Isolated MPs were fixed for transmission electron microscopy or processed for component analysis by flow cytometry, Western blot analysis, and confocal microscopy. RESULTS: Transmission electron microscopy showed that MPs ranged in diameter from 100 to 1000 nm. H2O2 treatment led to time- and dose-dependent elevations in MPs with externalized phosphatidylserine and phosphatidylethanolamine, known markers of MPs. These increases were strongly correlated to RPE apoptosis. Oxidative stress significantly increased the release of mCRP-positive MPs, which were prevented by a thiol antioxidant, N-acetylcysteine amide (NACA). CONCLUSIONS: This is the first evidence that oxidative stress induces cultured human RPE cells to release MPs that carry mCRPs on their surface. The levels of released MPs are strongly correlated with RPE apoptosis. N-acetylcysteine amide prevents oxidative stress-induced effects. Our findings indicate that oxidative stress reduces mCRPs on the RPE surface through releasing MPs.


Subject(s)
Acetylcysteine/analogs & derivatives , Cell-Derived Microparticles/metabolism , Oxidative Stress/drug effects , Retinal Pigment Epithelium/drug effects , Acetylcysteine/pharmacology , Blotting, Western , CD55 Antigens/metabolism , CD59 Antigens/metabolism , Cell-Derived Microparticles/ultrastructure , Cells, Cultured , Flow Cytometry , Humans , Hydrogen Peroxide/pharmacology , Male , Membrane Cofactor Protein/metabolism , Microscopy, Confocal , Microscopy, Electron, Transmission , Middle Aged , Oxidants/pharmacology , Retinal Pigment Epithelium/metabolism
5.
Microcirculation ; 22(1): 19-27, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25079175

ABSTRACT

OBJECTIVE: The effect of the heptapeptide hormone Ang-(1-7) on microvascular fibrosis in rats with Ang II-induced hypertension was investigated, since vascular fibrosis/remodeling plays a prominent role in hypertension-induced end-organ damage and Ang-(1-7) inhibits vascular growth and fibrosis. METHODS: Fibrosis of cremaster microvessels was studied in male Lewis rats infused with Ang II and/or Ang-(1-7). RESULTS: Ang II elevated systolic blood pressure by approximately 40 mmHg, while blood pressure was not changed by Ang-(1-7). Ang II increased perivascular fibrosis surrounding 20-50 µm arterioles as well as interstitial fibrosis; coadministration of Ang-(1-7) prevented the increases in fibrosis. The fibrotic factor CTGF and phospho-Smad 2/3, which upregulates CTGF, were increased by Ang II; this effect was prevented by coadministration of Ang-(1-7). Although TGF-ß phosphorylates Smad 2/3, TGF-ß was no different among treatment groups. In contrast, Ang II increased the MAP kinase phospho-ERK1/2, which also phosphorylates Smad; p-ERK was reduced by Ang-(1-7). Ang-(1-7), in the presence or absence of Ang II, upregulated the MAP kinase phosphatase DUSP1. CONCLUSIONS: These results suggest that Ang-(1-7) increases DUSP1 to reduce MAP kinase/Smad/CTGF signaling and decrease fibrosis in resistance arterioles, to attenuate end-organ damage associated with chronic hypertension.


Subject(s)
Angiotensin I/pharmacology , Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Hypertension/metabolism , Muscle, Skeletal/blood supply , Muscle, Skeletal/metabolism , Peptide Fragments/pharmacology , Angiotensin II/pharmacology , Animals , Arterioles/metabolism , Arterioles/pathology , Arterioles/physiopathology , Chronic Disease , Connective Tissue Growth Factor/metabolism , Dual Specificity Phosphatase 1/metabolism , Fibrosis/metabolism , Fibrosis/pathology , Fibrosis/physiopathology , Hypertension/drug therapy , Hypertension/pathology , Hypertension/physiopathology , MAP Kinase Signaling System/drug effects , Male , Mitogen-Activated Protein Kinase 3/metabolism , Muscle, Skeletal/pathology , Muscle, Skeletal/physiopathology , Phosphorylation/drug effects , Rats , Rats, Inbred Lew , Smad2 Protein/metabolism , Smad3 Protein/metabolism , Transforming Growth Factor beta/metabolism , Vasoconstrictor Agents/pharmacology
6.
J Cardiovasc Pharmacol ; 57(5): 598-603, 2011 May.
Article in English | MEDLINE | ID: mdl-21326105

ABSTRACT

Our studies in the mRen2.Lewis female rat, an angiotensin II- and estrogen-dependent model of hypertension, revealed that chronic activation of estrogen receptor GPR30 markedly reduces blood pressure in ovariectomized females. The present studies measured acute vasodilation to the selective GPR30 agonist G-1 and 17-ß-estradiol (10(-9)-10(-5.5) M) in isolated aortic rings and mesenteric arteries from intact mRen2.Lewis females. Maximal relaxation was greater in mesenteric vessels versus the aorta for both G-1 (47% ± 8% vs 80% ± 5% of phenylephrine preconstriction, P < 0.001) and estradiol (42% ± 7% vs 83% ± 4% of phenylephrine preconstriction, P < 0.001). The GPR30 antagonist G15 attenuated the response to both estradiol and G-1. Removal of the endothelium or pretreatment with Nitro-L-arginine methyl ester (L-NAME) partially attenuated vasorelaxation. Responses were not altered in mesenteric vessels from ovariectomized females. Immunohistochemical analysis revealed GPR30 expression in mesenteric endothelial and smooth muscle cells, and smooth muscle expression was confirmed in cultured cells. We conclude that estradiol-induced relaxation in conduit and resistance vessels from mRen2.Lewis females may be mediated by the novel estrogen receptor GPR30. The direct vasodilatory response of G-1 in resistance vessels presents one mechanism for the reduction in blood pressure induced by chronic G-1 administration.


Subject(s)
Cyclopentanes/pharmacology , Estradiol/pharmacology , Hypertension , Quinolines/pharmacology , Receptors, G-Protein-Coupled/agonists , Vasodilation/drug effects , Animals , Aorta/drug effects , Aorta/physiology , Blood Pressure/drug effects , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Female , Hypertension/metabolism , Hypertension/physiopathology , Immunohistochemistry , In Vitro Techniques , Mesenteric Arteries/drug effects , Mesenteric Arteries/physiology , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/metabolism , Ovariectomy , Rats , Rats, Inbred Lew , Receptors, G-Protein-Coupled/genetics , Vascular Resistance/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL